EP1221945A4 - Methods, pharmaceutical and therapeutic compositions for administering adenosine - Google Patents

Methods, pharmaceutical and therapeutic compositions for administering adenosine

Info

Publication number
EP1221945A4
EP1221945A4 EP00970984A EP00970984A EP1221945A4 EP 1221945 A4 EP1221945 A4 EP 1221945A4 EP 00970984 A EP00970984 A EP 00970984A EP 00970984 A EP00970984 A EP 00970984A EP 1221945 A4 EP1221945 A4 EP 1221945A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical
methods
therapeutic compositions
administering adenosine
adenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00970984A
Other languages
German (de)
French (fr)
Other versions
EP1221945A1 (en
Inventor
Eliezer Rapaport
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1221945A1 publication Critical patent/EP1221945A1/en
Publication of EP1221945A4 publication Critical patent/EP1221945A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00970984A 1999-10-20 2000-10-18 Methods, pharmaceutical and therapeutic compositions for administering adenosine Withdrawn EP1221945A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16063499P 1999-10-20 1999-10-20
US160634P 1999-10-20
PCT/US2000/028769 WO2001028528A1 (en) 1999-10-20 2000-10-18 Methods, pharmaceutical and therapeutic compositions for administering adenosine

Publications (2)

Publication Number Publication Date
EP1221945A1 EP1221945A1 (en) 2002-07-17
EP1221945A4 true EP1221945A4 (en) 2005-06-15

Family

ID=22577721

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00970984A Withdrawn EP1221945A4 (en) 1999-10-20 2000-10-18 Methods, pharmaceutical and therapeutic compositions for administering adenosine

Country Status (3)

Country Link
EP (1) EP1221945A4 (en)
AU (1) AU8028600A (en)
WO (1) WO2001028528A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068104A1 (en) 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
WO2006020703A1 (en) 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0344795A1 (en) * 1988-06-03 1989-12-06 Senju Pharmaceutical Co., Ltd. Stabilized pharmaceutical composition and method of producing same
EP0348688A1 (en) * 1988-06-03 1990-01-03 Senju Pharmaceutical Co., Ltd. Solid pharmaceutical preparation and method of producing same
EP0352477A2 (en) * 1988-07-25 1990-01-31 Eliezer Rapaport Use of adenosine 5'-phosphat in the treatment of cancer cachexia
WO1993021783A1 (en) * 1992-05-06 1993-11-11 The Penn State Research Foundation Methods of treating obesity with purine related compounds
US5547942A (en) * 1994-01-04 1996-08-20 Rapaport; Eliezer Method of treatment of diabetes mellitus by administration of adenosine 5'-t

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0344795A1 (en) * 1988-06-03 1989-12-06 Senju Pharmaceutical Co., Ltd. Stabilized pharmaceutical composition and method of producing same
EP0348688A1 (en) * 1988-06-03 1990-01-03 Senju Pharmaceutical Co., Ltd. Solid pharmaceutical preparation and method of producing same
EP0352477A2 (en) * 1988-07-25 1990-01-31 Eliezer Rapaport Use of adenosine 5'-phosphat in the treatment of cancer cachexia
WO1993021783A1 (en) * 1992-05-06 1993-11-11 The Penn State Research Foundation Methods of treating obesity with purine related compounds
US5547942A (en) * 1994-01-04 1996-08-20 Rapaport; Eliezer Method of treatment of diabetes mellitus by administration of adenosine 5'-t

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAARTINEN J M ET AL: "ATTENUATED ADENOSINE-SENSITIVITY AND DECREASED ADENOSINE-RECEPTOR NUMBER IN ADIPOCYTE PLASMA MEMBRANES IN HUMAN OBESITY", BIOCHEMICAL JOURNAL, vol. 279, no. 1, 1991, pages 17 - 22, XP009046533, ISSN: 0264-6021 *
See also references of WO0128528A1 *

Also Published As

Publication number Publication date
WO2001028528A1 (en) 2001-04-26
EP1221945A1 (en) 2002-07-17
AU8028600A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
CZ20012028A3 (en) Novel N-substituted 2-cyanopyrrolidines, pharmaceutical preparation in which they are comprised and their use as medicament
HUP0204515A3 (en) 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL149224A0 (en) Hydrogen-driven drug dosage form
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL150346A0 (en) Benzazole derivatives, their preparation and pharmaceutical compositions containing them
HK1040398A1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
HUP0301333A3 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
HUP0201649A2 (en) Purine derivatives, preparation method and pharmaceutical compositions containing same
HUP0201315A3 (en) 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203627A3 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them
HUP0500958A3 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
HUP0201797A3 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EP1221945A4 (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
GB9902227D0 (en) Pharmaceutical composition for topical administration
PL325509A1 (en) Therapeutic agent for oral administration
EP1188440A4 (en) Medicinal composition for oral administration
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
SI1161434T1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
SI1183256T1 (en) Purine derivatives, preparation method and pharmaceutical compositions containing same
IL128582A0 (en) Pharmaceutical dosage form

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020423

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050503

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/7076 B

Ipc: 7A 61K 9/28 A

Ipc: 7A 61P 3/04 B

17Q First examination report despatched

Effective date: 20050728

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20100301